Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The multiple sclerosis risk gene IL22RA2 contributes to a more severe murine autoimmune neuroinflammation.
Colour vision impairment is associated with disease severity in multiple sclerosis.
Epstein-Barr virus neuraxis infection as a trigger for central nervous system demyelinating processes: a case report.
Bipolar disorder and multiple sclerosis: A case series.
Human glial chimeric mice reveal astrocytic dependence of JC virus infection.
Modelling Genetic Susceptibility to Multiple Sclerosis with Family Data.
Using Observational Analysis of Multiple Sclerosis Relapse to Design Outcomes-Based Contracts for Disease-Modifying Drugs: A Feasibility Assessment.
A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosis.
Reducing survey burden: feasibility and validity of PROMIS measures in multiple sclerosis.
Glatiramer acetate to treat multiple sclerosis during pregnancy and lactation: a safety evaluation.
Cerebrospinal fluid myelin basic protein is frequently ordered but has little value: a test utilization study.
Development of a cell-based assay for the detection of anti-aquaporin 1 antibodies in neuromyelitis optica spectrum disorders.
Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions.
[Contrast agents in MRI-diagnosis of multiple sclerosis].
Emerging Subspecialties in Neurology: Palliative care.
Effect of integrated Yoga on neurogenic bladder dysfunction in patients with multiple sclerosis-A prospective observational case series.
Association of sex hormones and glucose metabolism with the severity of multiple sclerosis.
Human Endogenous Retrovirus HERV-Fc1 Association with Multiple Sclerosis Susceptibility: A Meta-Analysis.
Signaling networks in MS: A systems-based approach to developing new pharmacological therapies.
Sox5 and c-Maf cooperatively induce Th17 cell differentiation via RORγt induction as downstream targets of Stat3.
Cortical thickness and surface area relate to specific symptoms in early relapsing-remitting multiple sclerosis.
The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
Autobiographical memory in multiple sclerosis patients: Assessment and cognitive facilitation.
The effects of identification with a support group on the mental health of people with multiple sclerosis.
Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS).

Pages